vaccine safety

FDA Restricts J&J’s COVID-19 Vaccine Due to Blood Clot Risk

DCGI Okays Covaxin For Young Adults Aged 12-18 Years, With Some Conditions

COVID-19: The Importance of Conditional Indemnity for Vaccine Makers

Pfizer’s New Vaccine Plant Has Persistent Mould Issues, History of Recalls

Why Do Novavax Vaccine Trials Results in the UK and South Africa Differ?

Home Secy Ajay Bhalla Asks States To Prosecute People for Vaccine Safety ‘Rumours’

What Does Treating Covaxin and Covishield ‘Equally’ Entail?